Impact of glucagon-like peptide 1 analogs on cognitive function among patients with type 2 diabetes mellitus: A systematic review and meta−analysis

BACKGROUND: Diabetes is an independent risk factor for cognitive impairment. However, little is known about the neuroprotective effects of glucagon-like peptide 1 (GLP-1) analogs on type 2 diabetes mellitus (T2DM). Herein, we assessed the impact of GLP-1 analogs on the general cognitive functioning...

Descripción completa

Detalles Bibliográficos
Autores principales: Luan, Sisi, Cheng, Wenke, Wang, Chenglong, Gong, Jianhong, Zhou, Jianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650490/
https://www.ncbi.nlm.nih.gov/pubmed/36387915
http://dx.doi.org/10.3389/fendo.2022.1047883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650490/
https://www.ncbi.nlm.nih.gov/pubmed/36387915
http://dx.doi.org/10.3389/fendo.2022.1047883

Ejemplares similares